Waters (WAT) Financials: Revenue & Earnings

WAT$457.60+4.52 +1.00%

$44.93B

Market Cap

198.98

P/E

28.38

Forward P/E

26

Score

AI Analysis

Snapshot

Waters doesn’t screen as a clean setup today — Stocklytics 26/100 leaves more to prove. Under the hood: P/E 199.0, rich vs its own history, plus latest revenue up ~7% YoY.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

12
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

42
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

23
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Waters Corporation (WAT) last printed $457.60. Equity value is $44.93B. Trailing earnings multiple 198.98. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$2.17B$2.31B$2.42B$2.41B$2.37B$2.79B$2.97B$2.96B$2.96B$3.17B

About

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Waters (WAT) Financials: Revenue & Earnings

WAT price $457.60 +4.52 +1.00%

Ticker
WAT
Price
$457.60
Change
+4.52 +1.00%
Market cap ?
$44.93B
P/E ?
198.98
Forward P/E ?
28.38
Dividend yield ?
0.00%
Beta ?
1.15
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
26
Value
12
Quality
23
Growth
42

Stocklytics score rationale: value 12, quality 23, growth 42.

AI Score 45. Waters Corporation has a high price-to-earnings ratio of approximately 196, indicating overvaluation relative to earnings. Additionally, the company has reported negative net income in recent quarters, with a net income of -136 million in Q2 2026, suggesting challenges in profitability despite a strong market cap of approximately 45.2 billion

Insights · Forecast · Financials · Learn

Stocklytics home · Screener